Effect of Saffron on depression and anxiety

Not Applicable

• Conditions: mixed depression and anxiety, type 2 diabetes.; Non-insulin-dependent diabetes mellitus, Other single mood [affective] disorders; E11 , F38.

• Registration Number: IRCT2015082623776N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Inclusion criteria were: type 2 diabetes mellitus; 40 to 65 years old; mild to moderate anxiety and depression; fasting blood glucose under 170 mg/dl; Body Mass Index (BMI) between 18.5 to 40 kg/m2. Exclusion criteria were: less than 40 and more than 65 years old; mental related drugs (such as anti-depression and anti-anxiety drugs) using; severe depression and anxiety; tobacco or opium using; insulin using; uncontrolled blood glucose; severe physical activity; severe stress at the near past; emotional defeat at the near past; hospitalization at the near past; pregnancy or lactating or patients programmed for pregnancy; other diseases than depression and anxiety; mental disorders in the first degree relatives; BMI less than 18.5 or more than 40 kg/m2.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Beck depression score. Timepoint: 8 weeks. Method of measurement: Beck questionnaire.;Beck anxiety. Timepoint: 8 weeks. Method of measurement: Beck questionnaire.;Hamilton depression score. Timepoint: 8 weeks. Method of measurement: Hamilton questionnaire.;Hamilton anxiety score. Timepoint: 8 weeks. Method of measurement: Hamilton questionnaire.